nodes	percent_of_prediction	percent_of_DWPC	metapath
Tafluprost—PTGS2—pancreatitis	0.841	1	CbGaD
Tafluprost—Conjunctivitis allergic—Hyoscyamine—pancreatitis	0.0256	0.488	CcSEcCtD
Tafluprost—PTGFR—Small Ligand GPCRs—MTNR1B—pancreatitis	0.00761	0.0714	CbGpPWpGaD
Tafluprost—PTGFR—Small Ligand GPCRs—CNR2—pancreatitis	0.00742	0.0696	CbGpPWpGaD
Tafluprost—Visual acuity reduced—Hyoscyamine—pancreatitis	0.00665	0.127	CcSEcCtD
Tafluprost—PTGFR—Small Ligand GPCRs—CNR1—pancreatitis	0.00532	0.05	CbGpPWpGaD
Tafluprost—Photophobia—Hyoscyamine—pancreatitis	0.00371	0.0708	CcSEcCtD
Tafluprost—Dry eye—Hyoscyamine—pancreatitis	0.00365	0.0697	CcSEcCtD
Tafluprost—Vision blurred—Propantheline—pancreatitis	0.00318	0.0607	CcSEcCtD
Tafluprost—Eye pain—Hyoscyamine—pancreatitis	0.00318	0.0606	CcSEcCtD
Tafluprost—PTGFR—GPCRs, Other—SMO—pancreatitis	0.0018	0.0169	CbGpPWpGaD
Tafluprost—Headache—Propantheline—pancreatitis	0.00173	0.0329	CcSEcCtD
Tafluprost—Vision blurred—Hyoscyamine—pancreatitis	0.00163	0.0311	CcSEcCtD
Tafluprost—PTGFR—Prostaglandin Synthesis and Regulation—PTGS2—pancreatitis	0.00161	0.0151	CbGpPWpGaD
Tafluprost—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—CTRB2—pancreatitis	0.00155	0.0145	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Other—CNR1—pancreatitis	0.00152	0.0143	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—CASR—pancreatitis	0.00128	0.012	CbGpPWpGaD
Tafluprost—Dyspnoea—Hyoscyamine—pancreatitis	0.00126	0.024	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—CCK—pancreatitis	0.00122	0.0115	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—TACR1—pancreatitis	0.00119	0.0112	CbGpPWpGaD
Tafluprost—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS1—pancreatitis	0.00117	0.011	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—CCKAR—pancreatitis	0.00117	0.011	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CASR—pancreatitis	0.00115	0.0108	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—CRP—pancreatitis	0.00113	0.0106	CbGpPWpGaD
Tafluprost—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—PRSS3—pancreatitis	0.00111	0.0104	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatitis	0.0011	0.0103	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—pancreatitis	0.00109	0.0103	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—pancreatitis	0.00106	0.01	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CCKAR—pancreatitis	0.00105	0.00983	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Other—HTR2A—pancreatitis	0.00104	0.00975	CbGpPWpGaD
Tafluprost—Pruritus—Hyoscyamine—pancreatitis	0.000998	0.019	CcSEcCtD
Tafluprost—PTGS2—Selenium Micronutrient Network—XDH—pancreatitis	0.000988	0.00928	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—MTNR1B—pancreatitis	0.000944	0.00886	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CNR2—pancreatitis	0.00092	0.00864	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatitis	0.000906	0.0085	CbGpPWpGaD
Tafluprost—Headache—Hyoscyamine—pancreatitis	0.000884	0.0169	CcSEcCtD
Tafluprost—PTGFR—G alpha (q) signalling events—BDKRB2—pancreatitis	0.000871	0.00817	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—PPY—pancreatitis	0.000836	0.00785	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CX3CL1—pancreatitis	0.000832	0.00781	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—GCG—pancreatitis	0.000825	0.00775	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatitis	0.000809	0.0076	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—MTNR1B—pancreatitis	0.000809	0.0076	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—KNG1—pancreatitis	0.000792	0.00743	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—TACR1—pancreatitis	0.000789	0.0074	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatitis	0.000789	0.0074	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—BDKRB2—pancreatitis	0.000779	0.00731	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatitis	0.000776	0.00728	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—EGR1—pancreatitis	0.000749	0.00703	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GCG—pancreatitis	0.000738	0.00693	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—CXCL8—pancreatitis	0.000733	0.00688	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—pancreatitis	0.000708	0.00665	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.000673	0.00632	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—pancreatitis	0.000665	0.00624	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.000661	0.0062	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—MPO—pancreatitis	0.000653	0.00613	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—LPL—pancreatitis	0.000649	0.00609	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—SCT—pancreatitis	0.000646	0.00606	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CASR—pancreatitis	0.000646	0.00606	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CX3CL1—pancreatitis	0.000633	0.00595	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—MPO—pancreatitis	0.000629	0.0059	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCK—pancreatitis	0.000616	0.00578	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—MTNR1B—pancreatitis	0.000616	0.00578	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.000613	0.00576	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CNR2—pancreatitis	0.000601	0.00564	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—TACR1—pancreatitis	0.000601	0.00564	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—PPP3CA—pancreatitis	0.000598	0.00561	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCKAR—pancreatitis	0.000591	0.00554	CbGpPWpGaD
Tafluprost—PTGFR—G alpha (q) signalling events—HTR2A—pancreatitis	0.000584	0.00548	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.000577	0.00541	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.000566	0.00531	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TACR1—pancreatitis	0.000562	0.00527	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.000525	0.00492	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—pancreatitis	0.000522	0.0049	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—PTHLH—pancreatitis	0.000511	0.00479	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—SMO—pancreatitis	0.000511	0.00479	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—TNF—pancreatitis	0.00051	0.00479	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PPY—pancreatitis	0.000472	0.00443	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—SST—pancreatitis	0.000467	0.00438	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—PPP3CA—pancreatitis	0.000456	0.00428	CbGpPWpGaD
Tafluprost—PTGFR—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.000451	0.00424	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—pancreatitis	0.000443	0.00416	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—BDKRB2—pancreatitis	0.000439	0.00412	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.000439	0.00412	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CNR1—pancreatitis	0.000431	0.00405	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PPY—pancreatitis	0.000429	0.00403	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—HSP90AB1—pancreatitis	0.000419	0.00394	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—GCG—pancreatitis	0.000416	0.00391	CbGpPWpGaD
Tafluprost—PTGS2—Overview of nanoparticle effects—IL6—pancreatitis	0.000412	0.00387	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—KNG1—pancreatitis	0.000399	0.00375	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.000387	0.00363	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—EGR1—pancreatitis	0.000377	0.00354	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—SCT—pancreatitis	0.000365	0.00343	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CASR—pancreatitis	0.000365	0.00343	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—MTNR1B—pancreatitis	0.000348	0.00327	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCK—pancreatitis	0.000348	0.00327	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CNR2—pancreatitis	0.000339	0.00319	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—TACR1—pancreatitis	0.000339	0.00319	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—pancreatitis	0.000338	0.00317	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCL5—pancreatitis	0.000334	0.00314	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCKAR—pancreatitis	0.000334	0.00313	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—SCT—pancreatitis	0.000331	0.00311	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CASR—pancreatitis	0.000331	0.00311	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—CRP—pancreatitis	0.000331	0.00311	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CX3CL1—pancreatitis	0.000325	0.00305	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—SMO—pancreatitis	0.000325	0.00305	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—pancreatitis	0.000324	0.00304	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCK—pancreatitis	0.000316	0.00297	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—MTNR1B—pancreatitis	0.000316	0.00297	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—TACR1—pancreatitis	0.000308	0.00289	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CNR2—pancreatitis	0.000308	0.00289	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—ICAM1—pancreatitis	0.000304	0.00285	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCKAR—pancreatitis	0.000303	0.00285	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.000302	0.00284	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.000299	0.0028	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—HTR2A—pancreatitis	0.000294	0.00276	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—NRAS—pancreatitis	0.00029	0.00272	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—PTHLH—pancreatitis	0.000289	0.00271	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PNLIP—pancreatitis	0.000283	0.00265	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—INS—pancreatitis	0.000277	0.0026	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—CCL2—pancreatitis	0.000272	0.00255	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—SST—pancreatitis	0.000264	0.00248	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—SMO—pancreatitis	0.000262	0.00246	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PTHLH—pancreatitis	0.000262	0.00246	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatitis	0.000259	0.00243	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—EGR1—pancreatitis	0.000256	0.00241	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—LEP—pancreatitis	0.000256	0.0024	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—ALB—pancreatitis	0.000254	0.00238	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PPY—pancreatitis	0.000253	0.00238	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—TNF—pancreatitis	0.000252	0.00236	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TLR4—pancreatitis	0.000251	0.00235	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—PPP3CA—pancreatitis	0.00025	0.00235	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—KRAS—pancreatitis	0.00025	0.00234	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—BDKRB2—pancreatitis	0.000248	0.00233	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.000248	0.00232	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CNR1—pancreatitis	0.000244	0.00229	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—ICAM1—pancreatitis	0.00024	0.00226	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—SST—pancreatitis	0.00024	0.00225	CbGpPWpGaD
Tafluprost—PTGFR—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	0.000239	0.00224	CbGpPWpGaD
Tafluprost—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—pancreatitis	0.000235	0.00221	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—GCG—pancreatitis	0.000235	0.00221	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	0.000234	0.00219	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CCL2—pancreatitis	0.00023	0.00216	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—KNG1—pancreatitis	0.000226	0.00212	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—BDKRB2—pancreatitis	0.000225	0.00211	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatitis	0.000223	0.00209	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CNR1—pancreatitis	0.000221	0.00208	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CCL2—pancreatitis	0.000215	0.00202	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—GCG—pancreatitis	0.000214	0.002	CbGpPWpGaD
Tafluprost—PTGS2—Aryl Hydrocarbon Receptor—HRAS—pancreatitis	0.000212	0.00199	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL1B—pancreatitis	0.000206	0.00194	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—KNG1—pancreatitis	0.000205	0.00192	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SCT—pancreatitis	0.000196	0.00184	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGG—pancreatitis	0.000196	0.00184	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASR—pancreatitis	0.000196	0.00184	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CX3CL1—pancreatitis	0.000192	0.0018	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	0.000189	0.00178	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CCL5—pancreatitis	0.000189	0.00177	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MTNR1B—pancreatitis	0.000187	0.00175	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCK—pancreatitis	0.000187	0.00175	CbGpPWpGaD
Tafluprost—PTGS2—Disease—CTRB2—pancreatitis	0.000183	0.00172	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CNR2—pancreatitis	0.000182	0.00171	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—A2M—pancreatitis	0.000182	0.00171	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TACR1—pancreatitis	0.000182	0.00171	CbGpPWpGaD
Tafluprost—PTGFR—GPCR ligand binding—CXCL8—pancreatitis	0.000182	0.00171	CbGpPWpGaD
Tafluprost—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	0.000181	0.0017	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—NRAS—pancreatitis	0.000179	0.00168	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCKAR—pancreatitis	0.000179	0.00168	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL5—pancreatitis	0.000171	0.00161	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CXCL8—pancreatitis	0.00017	0.0016	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGA—pancreatitis	0.000167	0.00156	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—HTR2A—pancreatitis	0.000166	0.00156	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	0.000165	0.00155	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL1B—pancreatitis	0.000163	0.00153	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—CASP3—pancreatitis	0.000163	0.00153	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	0.00016	0.0015	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SMO—pancreatitis	0.000155	0.00145	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PTHLH—pancreatitis	0.000155	0.00145	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—KRAS—pancreatitis	0.000154	0.00145	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—CTRB2—pancreatitis	0.000153	0.00144	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—FGB—pancreatitis	0.000151	0.00142	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HTR2A—pancreatitis	0.000151	0.00142	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—TNF—pancreatitis	0.00015	0.00141	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PPP3CA—pancreatitis	0.000148	0.00139	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SST—pancreatitis	0.000142	0.00133	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—DUSP6—pancreatitis	0.00014	0.00132	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRSS1—pancreatitis	0.000139	0.0013	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—BDKRB2—pancreatitis	0.000133	0.00125	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—FDX1—pancreatitis	0.000133	0.00125	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PNLIP—pancreatitis	0.000132	0.00124	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PRSS3—pancreatitis	0.000132	0.00124	CbGpPWpGaD
Tafluprost—PTGS2—C-MYB transcription factor network—HRAS—pancreatitis	0.000131	0.00123	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CNR1—pancreatitis	0.000131	0.00123	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TGFB1—pancreatitis	0.000127	0.00119	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—GCG—pancreatitis	0.000126	0.00118	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	0.000124	0.00116	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADH4—pancreatitis	0.000124	0.00116	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KNG1—pancreatitis	0.000121	0.00114	CbGpPWpGaD
Tafluprost—PTGS2—Selenium Micronutrient Network—IL6—pancreatitis	0.000121	0.00113	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—TNF—pancreatitis	0.000118	0.00111	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CCL2—pancreatitis	0.000118	0.00111	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LTF—pancreatitis	0.000118	0.00111	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PRSS1—pancreatitis	0.000116	0.00109	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—PDGFA—pancreatitis	0.000111	0.00105	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	0.000111	0.00104	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PRSS3—pancreatitis	0.00011	0.00103	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PNLIP—pancreatitis	0.00011	0.00103	CbGpPWpGaD
Tafluprost—PTGFR—GPCR downstream signaling—CXCL8—pancreatitis	0.000103	0.000965	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL5—pancreatitis	0.000101	0.00095	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LPL—pancreatitis	9.9e-05	0.000929	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—XDH—pancreatitis	9.89e-05	0.000928	CbGpPWpGaD
Tafluprost—PTGS2—Spinal Cord Injury—IL6—pancreatitis	9.56e-05	0.000897	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—SPP1—pancreatitis	9.38e-05	0.00088	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—CXCL8—pancreatitis	9.34e-05	0.000876	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ADH1B—pancreatitis	9.22e-05	0.000866	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HTR2A—pancreatitis	8.93e-05	0.000838	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	8.68e-05	0.000814	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	8.63e-05	0.00081	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—LEP—pancreatitis	8.3e-05	0.000779	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	8.06e-05	0.000756	CbGpPWpGaD
Tafluprost—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	7.99e-05	0.00075	CbGpPWpGaD
Tafluprost—PTGS2—Disease—FGA—pancreatitis	7.76e-05	0.000728	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—NRAS—pancreatitis	7.49e-05	0.000703	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PLA2G1B—pancreatitis	7.36e-05	0.00069	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—A2M—pancreatitis	7.1e-05	0.000667	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—INS—pancreatitis	7.09e-05	0.000666	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CCL2—pancreatitis	6.98e-05	0.000655	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PPP3CA—pancreatitis	6.88e-05	0.000646	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALDH2—pancreatitis	6.5e-05	0.00061	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—KRAS—pancreatitis	6.45e-05	0.000605	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	6.34e-05	0.000595	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—MDM2—pancreatitis	5.9e-05	0.000554	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	5.7e-05	0.000535	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CXCL8—pancreatitis	5.52e-05	0.000518	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—HRAS—pancreatitis	5.48e-05	0.000514	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—CASP3—pancreatitis	5.28e-05	0.000495	CbGpPWpGaD
Tafluprost—PTGFR—Signaling by GPCR—IL6—pancreatitis	5.24e-05	0.000492	CbGpPWpGaD
Tafluprost—PTGS2—Disease—PDGFA—pancreatitis	5.19e-05	0.000487	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—GCG—pancreatitis	4.92e-05	0.000462	CbGpPWpGaD
Tafluprost—PTGS2—Disease—LPL—pancreatitis	4.61e-05	0.000433	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—NRAS—pancreatitis	4.42e-05	0.000415	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—TGFB1—pancreatitis	4.11e-05	0.000386	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—LPL—pancreatitis	3.86e-05	0.000363	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—KRAS—pancreatitis	3.81e-05	0.000357	CbGpPWpGaD
Tafluprost—PTGS2—Disease—INS—pancreatitis	3.3e-05	0.00031	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—HRAS—pancreatitis	3.24e-05	0.000304	CbGpPWpGaD
Tafluprost—PTGFR—Signaling Pathways—IL6—pancreatitis	3.1e-05	0.000291	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—PPARG—pancreatitis	2.82e-05	0.000265	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—INS—pancreatitis	2.77e-05	0.00026	CbGpPWpGaD
Tafluprost—PTGS2—Disease—MDM2—pancreatitis	2.75e-05	0.000258	CbGpPWpGaD
Tafluprost—PTGS2—Metabolism—ALB—pancreatitis	2.54e-05	0.000238	CbGpPWpGaD
Tafluprost—PTGS2—Disease—NRAS—pancreatitis	2.06e-05	0.000194	CbGpPWpGaD
Tafluprost—PTGS2—Disease—TGFB1—pancreatitis	1.92e-05	0.00018	CbGpPWpGaD
Tafluprost—PTGS2—Disease—KRAS—pancreatitis	1.77e-05	0.000167	CbGpPWpGaD
Tafluprost—PTGS2—Disease—HRAS—pancreatitis	1.51e-05	0.000142	CbGpPWpGaD
Tafluprost—PTGS2—Disease—IL6—pancreatitis	1.44e-05	0.000136	CbGpPWpGaD
